1. Home
  2. CAAS vs RANI Comparison

CAAS vs RANI Comparison

Compare CAAS & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.56

Market Cap

130.6M

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.38

Market Cap

132.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
RANI
Founded
N/A
2012
Country
China
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.6M
132.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CAAS
RANI
Price
$4.56
$1.38
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.67
AVG Volume (30 Days)
26.0K
1.2M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
5.68
N/A
EPS
1.11
N/A
Revenue
$725,260,000.00
$1,200,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
$4.13
N/A
Revenue Growth
16.72
N/A
52 Week Low
$3.50
$0.39
52 Week High
$5.37
$3.87

Technical Indicators

Market Signals
Indicator
CAAS
RANI
Relative Strength Index (RSI) 50.81 42.92
Support Level $4.51 $1.34
Resistance Level $4.79 $1.44
Average True Range (ATR) 0.19 0.07
MACD -0.01 0.00
Stochastic Oscillator 20.69 21.74

Price Performance

Historical Comparison
CAAS
RANI

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: